Engineering Smarter, Targeted Immunotherapies for Cancer and Autoimmune
The Immunotherapy Stream at PEGS Boston delves into cutting-edge engineering strategies revolutionizing immunotherapies for cancer and autoimmune diseases via antibody and cell-based approaches.
Part One explores recent breakthroughs in understanding and enhancing the immune system, TCR therapies, immune cell engagers, agonists, cytokines, identifying new targets via ML and AI, targeting solid tumors, and improving safety and efficacy. Part Two focuses on advancing next-generation cellular immunotherapies to combat solid tumors and autoimmune disorders, CAR T cells, NKs, TILs, Tregs, synthetic biology, and combination strategies. Part Three tackles next-generation approaches such as in vivo reprogramming of immune cells, mRNA therapies, cancer vaccines, oncolytic therapies, and gene-edited therapies. Together these tracks provide a clear vision on the future of immunotherapies across a range of modalities and indications.
Conferences Include:
May 12-13
Advances in Immunotherapy
May 13-14
Engineering Cell Therapies
May 15-16
Next-Generation Immunotherapies